Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27637 | 224 | 24.4 | 28% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
896 | 2 | AMIODARONE//ANTIARRHYTHMIC DRUGS//PROPAFENONE | 11339 |
27637 | 1 | N ACETYLPROCAINAMIDE//ABUNDANCE OF ECTOPARASITES//ANTIARRHYTHMIC PROCANBIDR | 224 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | N ACETYLPROCAINAMIDE | authKW | 513191 | 4% | 47% | 8 |
2 | ABUNDANCE OF ECTOPARASITES | authKW | 136319 | 0% | 100% | 1 |
3 | ANTIARRHYTHMIC PROCANBIDR | authKW | 136319 | 0% | 100% | 1 |
4 | DRUG EVOLUTION | authKW | 136319 | 0% | 100% | 1 |
5 | ETHNICITY EFFECTS ON PK PD | authKW | 136319 | 0% | 100% | 1 |
6 | HOP MAISONNEUVE ROSEMONT SERV NEPHROL | address | 136319 | 0% | 100% | 1 |
7 | HOP MAISONNEUVE ROSEMONT SERV SOINS INTENS | address | 136319 | 0% | 100% | 1 |
8 | MURINE RODENT COMMUNITIES | authKW | 136319 | 0% | 100% | 1 |
9 | PATHOLCLIN CHEM S | address | 136319 | 0% | 100% | 1 |
10 | PLASTICITY OF COMMUNITIES | authKW | 136319 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1158 | 42% | 0% | 95 |
2 | Cardiac & Cardiovascular System | 514 | 20% | 0% | 44 |
3 | Medical Laboratory Technology | 254 | 6% | 0% | 13 |
4 | Toxicology | 119 | 8% | 0% | 17 |
5 | Peripheral Vascular Diseases | 109 | 7% | 0% | 16 |
6 | Biology | 103 | 7% | 0% | 15 |
7 | Chemistry, Medicinal | 78 | 6% | 0% | 14 |
8 | Medicine, General & Internal | 64 | 9% | 0% | 21 |
9 | Chemistry, Multidisciplinary | 15 | 8% | 0% | 19 |
10 | Gastroenterology & Hepatology | 13 | 3% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HOP MAISONNEUVE ROSEMONT SERV NEPHROL | 136319 | 0% | 100% | 1 |
2 | HOP MAISONNEUVE ROSEMONT SERV SOINS INTENS | 136319 | 0% | 100% | 1 |
3 | PATHOLCLIN CHEM S | 136319 | 0% | 100% | 1 |
4 | U195 | 34078 | 0% | 25% | 1 |
5 | LILLIE FRANK ABERCROMBIE SECT PEDIAT CARDIOL | 1173 | 0% | 1% | 1 |
6 | ANIM SYSTEMAT ECOL | 620 | 0% | 0% | 1 |
7 | QUEBEC HEART | 398 | 0% | 0% | 1 |
8 | PARKE DAVIS PHARMACEUT | 291 | 0% | 0% | 1 |
9 | PHARMACOKINET DRUG METAB | 180 | 0% | 0% | 1 |
10 | EXPT CLIN PHARMACOL TOXICOL | 99 | 0% | 0% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IZVESTIYA AKADEMII NAUK SSSR SERIYA BIOLOGICHESKAYA | 22072 | 6% | 1% | 14 |
2 | THERAPEUTIC DRUG MONITORING | 2946 | 4% | 0% | 9 |
3 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2822 | 5% | 0% | 11 |
4 | ANGIOLOGY | 2404 | 4% | 0% | 9 |
5 | LEBER MAGEN DARM | 2106 | 1% | 1% | 3 |
6 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 1101 | 1% | 0% | 3 |
7 | MODERN CONCEPTS OF CARDIOVASCULAR DISEASE | 951 | 0% | 1% | 1 |
8 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 783 | 4% | 0% | 8 |
9 | JOURNAL OF PHARMACEUTICAL SCIENCES | 768 | 4% | 0% | 8 |
10 | CLINICAL PHARMACY | 708 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | N ACETYLPROCAINAMIDE | 513191 | 4% | 47% | 8 | Search N+ACETYLPROCAINAMIDE | Search N+ACETYLPROCAINAMIDE |
2 | ABUNDANCE OF ECTOPARASITES | 136319 | 0% | 100% | 1 | Search ABUNDANCE+OF+ECTOPARASITES | Search ABUNDANCE+OF+ECTOPARASITES |
3 | ANTIARRHYTHMIC PROCANBIDR | 136319 | 0% | 100% | 1 | Search ANTIARRHYTHMIC+PROCANBIDR | Search ANTIARRHYTHMIC+PROCANBIDR |
4 | DRUG EVOLUTION | 136319 | 0% | 100% | 1 | Search DRUG+EVOLUTION | Search DRUG+EVOLUTION |
5 | ETHNICITY EFFECTS ON PK PD | 136319 | 0% | 100% | 1 | Search ETHNICITY+EFFECTS+ON+PK+PD | Search ETHNICITY+EFFECTS+ON+PK+PD |
6 | MURINE RODENT COMMUNITIES | 136319 | 0% | 100% | 1 | Search MURINE+RODENT+COMMUNITIES | Search MURINE+RODENT+COMMUNITIES |
7 | PLASTICITY OF COMMUNITIES | 136319 | 0% | 100% | 1 | Search PLASTICITY+OF+COMMUNITIES | Search PLASTICITY+OF+COMMUNITIES |
8 | PROCAINAMIDE TWICE DAILY FORMULATION | 136319 | 0% | 100% | 1 | Search PROCAINAMIDE+TWICE+DAILY+FORMULATION | Search PROCAINAMIDE+TWICE+DAILY+FORMULATION |
9 | PROCAINAMIDE | 70313 | 4% | 6% | 9 | Search PROCAINAMIDE | Search PROCAINAMIDE |
10 | ACECAINIDE | 45438 | 0% | 33% | 1 | Search ACECAINIDE | Search ACECAINIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HARRON, DWG , BROGDEN, RN , (1990) ACECAINIDE (N-ACETYLPROCAINAMIDE) - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CARDIAC-ARRHYTHMIAS.DRUGS. VOL. 39. ISSUE 5. P. 720 -740 | 32 | 68% | 8 |
2 | ATKINSON, AJ , RUO, TI , PIERGIES, AA , (1988) COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE.ANGIOLOGY. VOL. 39. ISSUE 7. P. 655-667 | 22 | 65% | 9 |
3 | LUDDEN, TM , CRAWFORD, MH , KENNEDY, GT , (1985) N-ACETYLPROCAINAMIDE KINETICS DURING INTRAVENOUS INFUSIONS AND SUBSEQUENT ORAL DOSES IN PATIENTS WITH CORONARY-ARTERY DISEASE AND VENTRICULAR ARRHYTHMIAS.PHARMACOTHERAPY. VOL. 5. ISSUE 1. P. 11-15 | 13 | 100% | 3 |
4 | ATKINSON, AJ , RUO, TI , (1986) PHARMACOKINETICS OF N-ACETYLPROCAINAMIDE.ANGIOLOGY. VOL. 37. ISSUE 12. P. 959-967 | 14 | 74% | 5 |
5 | WHITE, SR , DY, G , WILSON, JM , (2002) THE CASE OF THE SLANDERED HALLOWEEN CUPCAKE: SURVIVAL AFTER MASSIVE PEDIATRIC PROCAINAMIDE OVERDOSE.PEDIATRIC EMERGENCY CARE. VOL. 18. ISSUE 3. P. 185-188 | 6 | 86% | 0 |
6 | JOSEPHSON, MA , SCHWAB, M , COYLE, K , SINGH, BN , (1987) EFFECTS OF INTRAVENOUS N-ACETYLPROCAINAMIDE ON HEMODYNAMICS AND LEFT-VENTRICULAR FUNCTION IN MAN.AMERICAN HEART JOURNAL. VOL. 113. ISSUE 4. P. 952-957 | 9 | 90% | 1 |
7 | YANG, BB , ABEL, RB , UPRICHARD, ACG , SMITHERS, JA , FORGUE, ST , (1996) PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISONS OF TWICE DAILY AND FOUR TIMES DAILY FORMULATIONS OF PROCAINAMIDE IN PATIENTS WITH FREQUENT VENTRICULAR PREMATURE DEPOLARIZATION.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 36. ISSUE 7. P. 623-633 | 5 | 100% | 7 |
8 | COYLE, JD , BOUDOULAS, H , LIMA, JJ , (1991) ACECAINIDE PHARMACOKINETICS IN NORMAL SUBJECTS OF KNOWN ACETYLATOR PHENOTYPE.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 12. ISSUE 8. P. 599-612 | 9 | 69% | 3 |
9 | LOW, CL , PHELPS, KR , BAILIE, GR , (1996) RELATIVE EFFICACY OF HAEMOPERFUSION, HAEMODIALYSIS AND CAPD IN THE REMOVAL OF PROCAINAMIDE AND NAPA IN A PATIENT WITH SEVERE PROCAINAMIDE TOXICITY.NEPHROLOGY DIALYSIS TRANSPLANTATION. VOL. 11. ISSUE 5. P. 881-884 | 5 | 100% | 5 |
10 | BOUCHER, M , CHASSAING, C , LABORDE, P , BREYSSE, C , HERBET, A , (1998) CARDIAC ANTICHOLINERGIC EFFECTS OF PROCAINAMIDE AND ITS N-ACETYLATED METABOLITE: EXPERIMENTAL PHARMACOLOGICAL AND RADIOLIGAND BINDING STUDIES.JOURNAL OF AUTONOMIC PHARMACOLOGY. VOL. 18. ISSUE 2. P. 83-87 | 5 | 83% | 3 |
Classes with closest relation at Level 1 |